Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. BDB749872

TCR Vβ8 Mouse anti-Human, BUV496, Clone: JR2, BD Biosciences™

Catalog No. BDB749872 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB749872 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. BDB749872 Supplier BD Biosciences Supplier No. 749872
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

TCR Vβ8 Monoclonal antibody specifically detects TCR Vβ8 in Human samples. It is validated for Flow Cytometry
TRUSTED_SUSTAINABILITY

Specifications

Antigen TCR Vβ8
Applications Flow Cytometry
Classification Monoclonal
Clone JR2
Conjugate Brilliant Ultraviolet 496
Formulation Aqueous buffered solution containing ≤0.09% sodium azide.
Gene Alias BV8; TCR Vβ8; TCR V beta 8; TCR Vb8
Host Species Mouse
Quantity 50 μg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV496 under optimal conditions that minimize unconjugated dye and antibody.
Isotype IgG2b κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.